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pre-invasive lesions; therefore, surgery should be carefully 
selected in such patients.
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Introduction
A ground-glass opacity (GGO) is defined as a shadow com-
pletely occupied by a hazy increased attenuation of the 
lung, with reservation of the bronchial and vascular mar-
gins in the lesion on HRCT. Among nodules detected on 
computed tomography (CT), a substantial number have 
GGO and are therefore referred to as ground-glass nodules 
(GGNs). Nonsolid GGNs (pure GGNs) are homogeneous 
lesions; however, they exhibit variations in the CT findings 
with respect to value and size. The histological features of 
persistent pure GGNs include atypical adenomatous hyper-
plasia (AAH), adenocarcinoma in situ (AIS), minimally 
invasive adenocarcinoma (MIA), and occasionally invasive 
adenocarcinoma (Ad.) such as lepidic predominant adeno-
carcinoma (LPA). The purpose of this study was to evalu-
ate the correlation between histological invasiveness and 
the CT value and size in pure GGNs to determine optimal 
“follow-up or resection” strategies for lesions displaying 
pure GGNs.
Patients and methods
We recommended resection of GGN lesions that did not 
decrease in size during 3 months of follow-up prior to 
2009. Since 2010, we defined GGN lesions with a maxi-
mum diameter >10 mm and CT value >−600 HU [1].
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Between April 2001 and September 2014, a total of 84 
pure GGNs in 81 patients were resected at our hospital. Of 
these, 78 nodules in 72 patients with pure GGNs ≤30 mm 
in size were evaluated in this retrospective analysis. Five 
patients had multiple pure GGNs, and three patients had 
pure GGNs and solid or partially solid adenocarcinomas.
During this period, 45 pure GGNs in 39 patients were 
followed up using HRCT at 4–6 months interval. Forty-one 
GGNs were lesions with a maximum diameter ≤10 mm or 
CT value ≤−600 HU, and four GGNs were lesions with a 
maximum diameter >10 mm and CT value >−600 HU.
Non-enhanced CT scans were performed from lung 
apices to bases during breath-holding at mid-inspira-
tion using a CT scanner (Aquilion 64, Toshiba, Tokyo, 
Japan). The helical scanning protocol was as follows: 
120 kVp; 200 mA; 0.5-s scanning time; window level, 
−500 Hounsfield units (HU); window width, 1600 HU; 
and a 512 × 512 matrix corresponding to a pixel size of 
approximately 0.6 mm. HRCT images were reconstructed 
at 0.5-mm intervals with a high-spiral-frequency algorithm 
(bone algorithm). Pure GGN was defined as a shadow 
completely occupied by a hazy increased attenuation of 
the lung, with reservation of the bronchial and vascular 
margins in the lesion with no solid regions on HRCT. The 
maximum diameter and CT value were measured using a 
computer graphics support system (HOPE/DrABLE-EX. 
Fujitsu, Tokyo, Japan). The CT value of each GGN lesion 
was measured in two or three areas excluding portions of 
apparent vessels, and the highest value in nonhomogeneous 
lesions was selected. Histological diagnoses were based on 
the new classification of lung adenocarcinoma proposed by 
the International Association for the Study of Lung Cancer, 
the American Thoracic Society, and the European Respira-
tory Society and classified as adenocarcinoma in situ (AIS), 
minimally invasive adenocarcinoma (MIA), and invasive 
adenocarcinoma (Ad.) [lepidic predominant adenocarci-
noma (LPA) and other histological subtypes] [2]. We clas-
sified AAH and AIS as pre-invasive lesions, and MIA and 
Ad. as invasive lesions. Radiologic findings of three repre-
sentative cases are shown in Fig. 1.
Statistical analyses were performed using SPSS II 
(SPSS Inc; Chicago, IL, USA). All data were expressed 
as the mean ± standard deviation (SD). The differences in 
mean and SD values were analyzed between groups using a 
two-tailed Student’s t test. Between-group differences with 
p values less than 0.05 were considered to be statistically 
significant.
Results
Patients ranged in age from 39 to 83 years (median, 
64 years). Forty patients were female and 32 were male. 
The maximum tumor dimension was ≤10 mm in 30 nod-
ules, 11–20 mm in 36 nodules, and 21–30 mm in 11 nod-
ules. The mean maximum tumor dimension of all cases 
was 12.9 ± 6.1 mm. The mean CT value of all cases was 
−569 ± 126 HU.
Fig. 1  Radiologic findings of pure GGN
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The mean interval from initial detection of focal 
GGO to pulmonary resection was 18 months (range 
3–130 months). Pathologic specimens demonstrated AAH 
in 10 nodules, AIS in 30 nodules, MIA in 19 nodules, and 
Ad. in 18 nodules, including 14 cases of LPA and lym-
phoproliferative disorder in 1 nodule. Surgical procedures 
included lobectomy in 30 nodules, segmentectomy in 
15 nodules, and partial resection in 32 nodules. None of 
the 47 patients, except for 1 with solid adenocarcinoma 
who underwent lymph node dissection and sampling, had 
lymph node involvement. All patients, except for two who 
died from other diseases and three who experienced recur-
rence accompanied with solid adenocarcinoma, have sur-
vived with no evidence of tumor recurrence to date, at a 
median follow-up of 46 months. Figure 2 shows the distri-
bution of the maximum diameter in AAH, AIS, MIA, and 
Ad. The mean maximum diameter in AAH, AIS, MIA, and 
Ad was 6.5 ± 0.5 mm, 11.4 ± 1.7 mm, 15.1 ± 1.5 mm, 
and 15.1 ± 5.5 mm, respectively. The percentage of inva-
sive lesions was 19 % (6/31) among lesions ≤10 mm (line 
A) and 38 % (20/53) in lesions ≤15 mm (line B). The 
difference between the noninvasive and invasive lesions 
was statistically significant (p < 0.05). Figure 3 shows 
the distribution of the CT values in AAH, AIS, MIA, and 
Ad. The mean CT value in AAH, AIS, MIA, and Ad was 
−699 ± 23 HU, −580 ± 120 HU, −509 ± 98 HU, and 
−532 ± 37 HU. All AAH lesions were less than −600 HU 
and had significantly lower CT values than AIS, MIA, and 
Ad. The differences between AIS and MIA or between the 
noninvasive and invasive lesions were statistically signifi-
cant (p < 0.05). No significant difference in the CT values 
was observed between MIA and Ad. Figure 4 illustrates 
the relationship between the CT value and maximum 
diameter of pure GGN lesions. All GGN lesions with a 
maximum diameter ≤10 mm and CT value ≤−600 HU 
were considered to be noninvasive lesions, while 21 of 
26 (81 %) with a maximum diameter >10 mm and CT 
value >−600 HU were considered to be invasive lesions. 
With respect to the correlation between each histologi-
cal type and pure GGN lesions with a maximum diameter 
≤10 mm and CT value ≤−600 HU, the specificity was 
90 % and the sensitivity and negative predictive values 
were 100 % in AAH, while the specificity was 58 %, and 
the sensitivity and positive predictive values were 0 % in 
MIA and Ad (Table 1).
Fig. 2  The plots of the maximum diameter in AAH, AIS, MIA, and 
Ad. The percentage of invasive lesions was 19 % (6/31) for lesions 
≤10 mm (line A), while it was 38 % (20/53) for lesions ≤15 mm (line 
B). The difference between the noninvasive and invasive lesions was 
significant (p < 0.05). Some plots with the same size overlap at the 
same point. Bars mean ± SD. AIS* adenocarcinoma in situ, MIA** 
minimally invasive adenocarcinoma, Ad.*** invasive adenocarcinoma
Fig. 3  CT values in AAH, AIS, MIA, and Ad. All AAH lesions were 
≤−600 HU and had significantly lower CT values than AIS, MIA, 
and Ad. The differences between AIS and MIA and between the non-
invasive and invasive lesions were significant (p < 0.05). No signifi-
cant difference in the CT values was observed between MIA and Ad. 
Some plots with the same CT value overlap at the same point. Bars 
mean ± SD
Fig. 4  Relationship between the CT value and maximum diameter 
of pure GGN lesions. All GGN lesions with a maximum diameter 
≤10 mm and CT value ≤−600 HU were noninvasive lesions, while 
21 of 26 (81 %) GGN lesions with a maximum diameter >10 mm and 
CT value >−600 HU were invasive lesions. Some plots with the same 
size and CT value overlap at the same point
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In 45 follow-up cases of GGNs, two (50 %) of four 
lesions with a maximum diameter >10 mm and CT value 
>−600 HU and 11 (24 %) of 41 lesions ≤10 mm or CT 
value ≤−600 HU had findings of increased size or CT 
number. The median follow-up period was 51 months.
Discussion
Many radiologic studies of small lung adenocarcinomas 
have demonstrated a strong correlation between the CT 
findings and pathologic features [3, 4]. Several groups 
have classified small lung lesions into the nonsolid (pure) 
GGO type, partly solid (mixed) GGO type, and solid type 
and have suggested that the pure type and mixed type 
with small solid components are nearly always noninva-
sive carcinomas [5–8]. However, it is occasionally dif-
ficult to differentiate between pure and mixed GGO and 
between high-density GGO and a solid tumor. Suzuki 
et al. classified homogeneous (so-called “pure”) GGO 
into pure GGO and semiconsolidation to evaluate the dif-
ferences in the density within the tumor and determined 
that, pathologically, semiconsolidation tends to be adeno-
carcinoma with invasive foci [9]. Although the differen-
tiation between pure GGN and semiconsolidation was 
unclear in their report, the density within homogeneous 
GGNs appears to be an important factor for predicting 
tumor invasiveness. We speculated that pure GGNs should 
be defined as homogeneous hazy lesions, for which CT 
values were ≤−300 HU in the present analysis. Because 
−300 HU is the limitation of differentiation between 
vessels, we classified lesions with CT values >−300 HU 
to be solid nodules.
Several groups have used quantitative densitometric 
methodologies to evaluate GGN lesions [10–13]. Ikeda 
et al. reported that the 75th percentile CT value analyzed 
using three-dimensional computerized quantification of 
the GGO lesions was the optimal value for differentiating 
between AAH, BAC, and adenocarcinoma. These inves-
tigators noted that a CT cutoff value of −584 HU was 
optimal for differentiating AAH and BAC, and −472 HU 
was optimal for differentiating BAC and adenocarcinoma 
[11]. Nomori et al. used histograms of CT pixel numbers 
for AAH and nonmucinous adenocarcinoma to quantify 
the peaks and mean numbers of CT pixels and found the 
mean CT values to be −697 ± 56 HU for AAH lesions 
and −541 ± 73 HU for BAC lesions. These investigators 
noted that the peak CT value on the histogram was the most 
frequent value observed in the tumor and that the effect of 
vessels and bronchi within the tumor can be ignored [12]. 
The CT value of each GGN lesion was measured in two 
or three areas, excluding the apparent vessels, in this study, 
and was the selected highest value in nonhomogeneous 
lesions. The present study demonstrates that a CT value of 
−600 HU may represent a cutoff value demarcating AAH 
versus invasive lesions. We believe that this finding could 
significantly impact the selection of therapeutic strategies 
for GGN lesions.
Whether GGN lesions that are suspected to be pre-
invasive or minimally invasive adenocarcinoma should 
be resected or followed up also remains controversial. 
Recently, several groups have reported that for pre-invasive 
Table 1  Correlation of histology and pure GGN lesions with a maximum diameter ≤10 mm and CT value ≤−600 HU
As concerns AAH, specificity is 90 %, sensitivity and negative predictive value are 100 %. While, in MIA and invasive adenocarcinoma, speci-
ficity is 58 %, sensitivity and positive predictive value are 0 %
AAH AAH nonAAH Total
≤−600 HU and ≤10 mm 10 7 17 Specificity 90 %
>−600 HU or > 10 mm 0 60 60 Sensitivity 100 %
Total 10 67 77 Positive predictive value 59 %
Negative predictive value 100 %
AIS AIS non AIS Total
≤−600 HU and ≤10 mm 7 10 17 Specificity 76 %
>−600 HU or >10 mm 23 28 60 Sensitivity 23 %
Total 30 37 77 Positive predictive value 41 %
Negative predictive value 47 %
MIA + Ad. MIA + Ad. Others Total
≤−600 HU and ≤10 mm 0 17 17 Specificity 58 %
>−600 HU or >10 mm 37 23 60 Sensitivity 0 %
Total 37 40 77 Positive predictive value 0 %
Negative predictive value 38 %
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lesions identified on HRCT, careful observation without 
surgical intervention represents a valid treatment option 
[14–16]. According to the interim guidelines suggested 
by Godoy and Nadich, isolated lesions with pure GGNs 
that are ≤5 mm do not necessarily require CT follow-up, 
since they nearly always represent foci of AAH; however, 
for lesions between 5 and 10 mm, follow-up is mandatory 
pending better definition of their true nature. Lesions >1 cm 
should be assumed to be so-called BAC or invasive adeno-
carcinoma; however surgery should be considered, particu-
larly if the nodule is growing or if an increase in attenua-
tion or development of a solid component is observed [17].
Diligent long-term follow-up of the natural history of 
pure GGN and should be conducted to determine whether 
surgical intervention is acceptable or unnecessary [18]. 
However, we believe that early detection and early therapy 
of some primary lung cancers with pure GGNs are impor-
tant for improving individual prognoses for the following 
reasons. First, pure GGN lesions are not all histologically 
pre-invasive, as some, such as MIA and LPA, have an Ad. 
component. Second, several groups have reported the con-
cept of a multi-step progression from AAH through local-
ized BAC (AIS and MIA) to advanced adenocarcinoma 
with a replacement growth pattern (LPA and other type of 
Ad.) [19–21]. Third, patients with LPA have a lower 5-year 
survival rate (approximately 93 %) than patients with AIS 
and MIA (100 %) [22–25]. Our therapeutic strategy for 
pure GGNs is to avoid unnecessary surgery for AAH and 
therapeutic delays for Ad.
There are some limitations associated with this study, 
such as a retrospective study design and small number of 
surgical cases. However, we revealed a correlation between 
the histology and pure GGN lesions with a maximum 
diameter ≤10 mm and CT value ≤−600 HU. With respect 
to AAH, the specificity was 90 % and the sensitivity and 
negative predictive values were both 100 %. In contrast to 
MIA and Ad., the specificity was 58 % and the sensitivity 
and positive predictive values were both 0 %. According to 
these results, we propose the follow-up criteria of a maxi-
mum diameter ≤10 mm and CT value ≤−600 HU for pure 
GGNs, and unnecessary surgery for AAH and therapeutic 
delay for Ad. can be avoided.
Conclusion
Pure GGNs at a maximum diameter of ≤10 mm and CT 
value of ≤−600 HU are nearly always pre-invasive lesions; 
therefore, surgery should be carefully selected in such 
patients.
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